dalteparin has been researched along with Delayed Hypersensitivity in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "These cases provide evidence of type IV hypersensitivity and the possibility of crossed-allergenicity among unfractionated heparin and low-molecular-weight heparins." | 1.30 | Delayed-type hypersensitivity to subcutaneous enoxaparin. ( Armentia, A; de la Fuente, R; Fernández, A; Martínez, C; Méndez, J; Sánchez, P; Sanchís, ME; Stolle, R; Vega, JM, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (44.44) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Colagiovanni, A | 1 |
| Rizzi, A | 1 |
| Buonomo, A | 1 |
| De Pasquale, T | 1 |
| Pecora, V | 1 |
| Sabato, V | 1 |
| Aruanno, A | 1 |
| Pascolini, L | 1 |
| Nucera, E | 1 |
| Schiavino, D | 1 |
| O'Meara, AC | 1 |
| Demarmels Biasiutti, F | 1 |
| Heizmann, M | 1 |
| Méndez, J | 2 |
| de la Fuente, R | 2 |
| Stolle, R | 2 |
| Vega, JM | 2 |
| Sanchís, ME | 2 |
| Armentia, A | 2 |
| Sánchez, P | 2 |
| Fernández, A | 2 |
| Valdés, F | 1 |
| Vidal, C | 1 |
| Fernández-Redondo, V | 1 |
| Peteiro, C | 1 |
| Toribio, J | 1 |
| Koch, P | 2 |
| Reinhold, S | 1 |
| Busch, C | 1 |
| Nicolie, B | 1 |
| Bonneau, JC | 1 |
| Le Sellin, J | 1 |
| Gay, G | 1 |
| Leclere, JM | 1 |
| Drouet, M | 1 |
| Dabas, G | 1 |
| De, D | 1 |
| Handa, S | 1 |
| Aggarwal, D | 1 |
| Hindi, S | 1 |
| Landwehr, D | 1 |
| Martínez, C | 1 |
2 reviews available for dalteparin and Delayed Hypersensitivity
| Article | Year |
|---|---|
Delayed hypersensitivity skin reaction to enoxaparin.
Topics: Administration, Topical; Adrenal Cortex Hormones; Aged; Anticoagulants; Drug Hypersensitivity; Enoxa | 1996 |
[Delayed hypersensitivity to heparins and heparinoids].
Topics: Aged; Anticoagulants; Chondroitin Sulfates; Cross Reactions; Dalteparin; Dermatan Sulfate; Drug Comb | 2002 |
7 other studies available for dalteparin and Delayed Hypersensitivity
| Article | Year |
|---|---|
Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested.
Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Anticoagulants; Breast Neoplasms; Drug | 2010 |
Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions.
Topics: Aged; Anticoagulants; Drug Eruptions; Fondaparinux; Humans; Hypersensitivity, Delayed; Injections, S | 2007 |
Eczema-like plaques to enoxaparin.
Topics: Anticoagulants; Cross Reactions; Drug Hypersensitivity; Eczema; Enoxaparin; Female; Heparin; Humans; | 1998 |
Delayed allergic skin reactions to subcutaneous heparins. Tolerance of 2 recombinant hirudins.
Topics: Anticoagulants; Cross Reactions; Dalteparin; Drug Hypersensitivity; Female; Hirudins; Humans; Hypers | 2000 |
Delayed-type hypersensitivity reaction to enoxaparin in a pregnant woman.
Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Enoxaparin; Female; Humans; Hypersensitivity, Dela | 2019 |
Delayed allergic skin reactions due to subcutaneous heparin-calcium, enoxaparin-sodium, pentosan polysulfate and acute skin lesions from systemic sodium-heparin.
Topics: Administration, Cutaneous; Anticoagulants; Drug Eruptions; Enoxaparin; Female; Fibrinolytic Agents; | 1996 |
Delayed-type hypersensitivity to subcutaneous enoxaparin.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Humans; Hypersensitivity, Delayed; Injections, Subcutaneou | 1998 |